December 16, 2025
Headlines

Medicine

UroMems Raises $47 Million in Series C Funding to Advance Groundbreaking Treatment for Stress Urinary Incontinence

Editor05 mins

UroMems, a pioneering global company specializing in mechatronics technology for treating stress urinary incontinence (SUI), has secured $47 million in its Series C financing round, marking a record fundraising achievement for the company. This capital infusion will propel pivotal clinical trials of their groundbreaking UroActive™ System, the world’s first smart automated artificial urinary sphincter (AUS)…

Read More
Stacey Pugh, CEO of Endogenex

Endogenex Secures $88 Million in Series C Funding to Advance Breakthrough Diabetes Treatment

Editor04 mins

Endogenex, a pioneering clinical-stage medical device company dedicated to transforming diabetes care, has successfully closed an oversubscribed Series C financing round, raising a remarkable $88 million. This substantial funding boost will propel the company towards completing its pivotal ReCET Clinical Study, a critical step in bringing their innovative ReCET™ System to market for patients suffering…

Read More

Vico Therapeutics Secures €65.8 Million in Series B Funding to Advance Groundbreaking Neurological Therapies

Editor04 mins

Vico Therapeutics, a pioneering clinical-stage genetic medicines company, has successfully closed its Series B funding round with a total investment of €65.8 million ($70.7 million). This financing round, led by Seroba and Kurma Partners, marks a significant milestone in Vico’s journey towards developing transformative therapies for severe neurological diseases. Vico Therapeutics specializes in antisense oligonucleotide…

Read More